加皇资本市场分析师Luca Issi维持$CRISPR Therapeutics(CRSP.US)$持有评级,并将目标价从53美元下调至48美元。根据TipRanks数据显示,该分析师近一年总胜率为24.7%,总平均回报率为-18.7%。提示: TipRanks为独立第三方,提供金融分析师的分析数据,并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议,仅供参考。
美银证券维持CRISPR Therapeutics(CRSP.US)买入评级,上调目标价至86美元 美银证券分析师Alec Stranahan维持$CRISPR Therapeutics(CRSP.US)$买入评级,并将目标价从85美元上调至86美元。根据TipRanks数据显示,该分析师近一年总胜率为34.8%,总平均回报率为-10.1%。提示: TipRanks为独立第三方,提供金融分析师的分析数据,...
Get CRISPR Therapeutics AG (CRSP:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
CRSP Stock Price Bull or Bear, Seeking Alpha is there Markets change, but our community always has the latest news, in-depth analysis, and powerful stock ratings. Continue with Google Continue with Apple or Create Free Account By creating an account using any of the options above, you agree...
A high-level overview of CRSP US Mid Cap Index (CRSPMI1) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Financial News London realtor.com Mansion Global Dow Jones Smart Money Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect ...
Baird, Rodman & Renshaw, Royal Bank of Canada, Stifel Nicolaus, StockNews.com, TheStreet, Truist Financial Co., Wells Fargo & Company, and Wolfe Research. View the latest analyst ratings for CRSP. What is the current price target for CRISPR Therapeutics? 0 Wall Street analysts have set ...
Discover real-time CRISPR Therapeutics AG Common Shares (CRSP) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
Stock Market News Today, 2/7/25 – Indices Fall after Nonfarm Payrolls Report 1d ago NDX SPX Trump Settlement Would “Cripple” Paramount (NASDAQ:PARA) 1d ago PARA Meta Platforms (META) to Layoff 5% of its Global Workforce 1d ago CRM AMZN Ford (NYS...
Bausch Health Companies Market Cap $3B Current Price $7.72 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. View Premium Services